PHOTO
The patient had the access to the UK’s healthcare system but opted for his surgery locally
Dubai: Iqbal Javed, a 60 year old Pakistani gentleman, living with his family in the UAE for a close to 30 years presented at emergency of the hospital with giddiness, sweating and a feeling of loss of consciousness.
Upon finding every neurological parameter as normal he was quickly referred to a cardiologist.
“We performed the Echo test to figure out what’s happening in his heart and found that there was a lump of mass (tumor) in the right side of the heart. The tumor was attached to its base on one end while moving and intermittently obstructing the tricuspid valve (one of the main valves in the heart that regulates the flow of blood) on the other hand describing the reason as to why he was experiencing giddiness on an intermittent basis”, explained Dr. Girish Chandra Varma, Consultant Cardio thoracic surgeon at NMC Speciality Hospital at Al Nahda.
Javed was having an active work life at Etisalat and had no major health issues except for few minor episodes giddiness few weeks back. He was taken by surprise at the diagnosis.
Dr. Varma continues, “He is an educated man whose daughter is studying Medicine in Ukraine had the access to the UK’s healthcare system, yet his decision to get operated here in his country of residence is a testimonial to the rise of healthcare standards in the country.”
Accordingly, he was taken up for the tumor excision and the doctors could remove the tumor mass completely after putting the patient on the heart and lung bypass machine. Such large tumors are not only rare but risky to operate and require not only skills sets of the surgeon but also need a support team and advanced life support equipment.
Dr. Varma further explained,” This golf ball sized tumor would have caused many complications by the obstructing the valve as such patients can unexpectedly collapse because of a sudden blockage of the blood flow retendering the outcome as fatal.”
Javed said, “I am grateful to Allah that I was diagnosed and treated at the right time. I am thankful to Dr. Girish Chandra Verma and his team for the support and strength they gave me before, during and after the procedure.”
Javed is recovering well and is looking forward to celebrating Eid with his loved ones.
Prasanth Manghat, NMC Health CEO and Executive Director said, “Cardiology services are the need of the Emirates and NMC has the largest cardiac services program in the private sector healthcare. Access to quality healthcare is a fundament right of every citizen and NMC is committed to ensure that the communities receive the best-in-class healthcare services.”
NMC draws on its vast experience of providing healthcare to millions of patients throughout the Middle East region and across the world and uses its reach and unrivalled healthcare network to deliver the best and most advanced medical services and facilities to communities.
About NMC Health
NMC Health plc is the leading private sector healthcare operator based out of the United Arab Emirates. The group, having started its operations in the country in 1975, has an international network of hospitals in the UAE & GCC, Europe and South America consisting of over 145 healthcare facilities across 13 countries, catering to over 8.5 million patients per year, and employing over 2000 doctors and 18000 administrative and support staff.
The group is also a leading UAE distributor of products and consumables across several key market segments, with the major contribution coming from healthcare related products. NMC Trading, a subsidiary of NMC Health plc, is one of the largest distributors in the UAE with distribution rights for some of the most iconic brands from around the world, including 3M, Medtronic, Welch Allyn, Meyra, Sorg, Patron, Abbott Diabetes Care, Nestle, Unilever, Nivea, Pfizer, Siemens, Samsung, Sanofi, Kiwi, Brylcreem, and Henkel, among others. NMC Trading sells products and services to over 10,000 businesses across the UAE.
NMC Health plc reported revenues of US$1603.4 m in 2017. In April 2012 NMC Health plc became the first healthcare company from the GCC to list on the London Stock Exchange (LSE). NMC Health plc is a constituent of the coveted FTSE 100 Index of the blue-chip companies at the LSE.
To find out more visit: https://nmc.ae/
-Ends-
© Press Release 2018Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
